Hi all,
I am pleased to read the announcement in July 2013 of Sanford- Burnham's research into SMIP004. I am all for the approach to down regulate the androgen receptors of cancerous cells. This is seen to be the first stage to arrest the rapid growing of the cancerous cells leading to metastasis.
SMIP004 is specifically good with prostrate cancer patients who have developed into the castration resistant stage and have cancer cells who are insensitive to androgen dripivation therapy.
Let us pray that SMIP004 will be successfully tried out in vivo and accepted by the FDA soonest.
Visit Here
for details.
Take care
Allen Lai
No comments:
Post a Comment